Microglia are the innate immune cells of the brain with roles in neuroimmunology and synaptic plasticity. Microglial processes continuously survey the brain parenchyma interacting with synaptic elements and maintaining tissue homeostasis. However, the mechanisms that control surveillance and its role in synaptic plasticity are poorly understood. Microglial dynamics in vivo have been primarily studied in anesthetized animals, where slow-wave neural activity resembles sleep-like states. We report that microglial surveillance and injury response in awake animals are reduced compared to when animals are anesthetized, suggesting that arousal state profoundly modulates microglial roles in the physiological brain. Stimulating β2-adrenergic receptors recapitulated these observations and also disrupted experience-dependent plasticity only when intact β2-adrenergic receptors were present in microglia specifically. These results indicate that microglial roles in surveillance and synaptic plasticity in the healthy brain are modulated by noradrenergic fluctuations between arousal states and raises new considerations for sleep/wake disruption in neurodevelopment and neuropathology.
Introduction
In recent years, the list of key regulators of synaptic function has expanded to include astrocytes and microglia as critical components in the synaptic unit of the "quad-partite" synapse 1 . However, the extent and mechanisms underlying this microglial role are still under debate. Microglia, the innate immune cells of the central nervous system (CNS), are exquisitely sensitive to changes in brain homeostasis and rapidly alter their morphology to respond to inflammatory signals. In the absence of injury or disease states, microglial arbors are highly ramified with dynamic processes that continually extend and retract through the parenchyma 2, 3 . Several recent in vivo imaging studies have shown that this microglial process motility permits microglial interactions with neural elements in diverse regions of the CNS [4] [5] [6] [7] , allowing microglia to modulate synaptic remodeling and neural plasticity through the release of growth factors and enzymes or through physical synaptic contact [8] [9] [10] . While several signaling pathways, such as fractalkine, complement, and purinergic signaling, have been identified as mediating microglial function during neural circuit pruning, development, and plasticity 8, [10] [11] [12] [13] , it remains largely unknown how other CNS signals, such as neurotransmitters, may regulate microglial function 14 .
Recent evidence suggests that glial physiology can be dramatically altered between sleep and wakeful states. For example, astrocytic calcium signaling increases during wakeful states and is relatively quiescent during sleep-like states 15 . However, studies of microglia have been performed primarily in reduced preparations or in anesthetized animals, leaving open the possibility that microglial dynamics and the resulting interactions with neurons may be altered in awake brains. In addition, extracellular space increases during sleep-like states 16 , which could greatly impact microglial surveillance, and contribute to the enhanced remodeling of synaptic structure 17 and increased activity-dependent plasticity 18 that occurs during sleep. Interestingly, in the non-injured brain, microglia have a high and selective expression of the β2 adrenergic receptor (β2-AR) relative to other CNS cell types 19, 20 , suggesting they may have unique responses to norepinephrine (NE), which potently modulates plasticity, learning, attention to salient stimuli, and sensory processing 17 . Furthermore, NE and β 2 -ARs can impact the microglial inflammatory response 19 , IL-1β production 20 , and ATP-driven chemotaxis by inhibiting the P2Y12 Gαi signaling pathway 21 . P2Y12 is also critical for experience-dependent plasticity in the mouse adolescent visual system, and its loss impairs both the microglial response and synaptic plasticity itself 10 Thus, NE could act through microglial β2-ARs to modulate microglial behavior during sleep/wake states and modulate P2Y12-dependent microglial processes that contribute to activity-dependent synaptic rearrangement.
Here, we characterize microglial dynamics in awake mice and describe the effect of microglial β2-AR signaling on in vivo microglial physiology and functions in synaptic plasticity. We demonstrate that microglia in the awake brain differ from those in anesthetized and "sleep-like" conditions in both baseline morphology and process dynamics as well as injury response. These findings suggest that microglial functions in awake conditions are fundamentally different than what has previously been described in anesthetized animals. We then recapitulate most of these changes through pharmacological stimulation or inhibition of microglial β2-ARs. Finally, we demonstrate that changes in microglial β2-AR and noradrenergic signaling impair ocular dominance plasticity. Our work shows the importance of microglial β2-AR signaling in regulating microglial surveillance of the brain, as well as the participation of these cells in experiencedependent plasticity, which provides new consideration for diseases in which sleep or NE homeostasis are disrupted.
Results

Anesthesia increases microglial surveillance of the CNS parenchyma
Most studies of microglial dynamics in vivo have been conducted in anesthetized animals or in ex vivo slice preparations 2, 3, 10, 14 . However, anesthesia substantially alters numerous facets of brain homeostasis through diverse actions on multiple cell types. To determine whether microglial behavior is affected by anesthesia, we imaged microglial dynamics in the same adult animals during anesthetized and wakeful states using the microglia-labeled CX3CR1 GFP transgenic mouse line and a chronic cranial window preparation. We found that compared to awake conditions, microglia in mice anesthetized with a commonly used fentanyl cocktail (also containing dexmedetomidine and midazolam) had significantly altered morphology. Quantification of microglial morphology using Sholl analysis revealed that microglia in anesthetized animals had more elaborate process arbors than when the animals were awake ( Fig.1a-d ; area under the curve (AUC); Paired t-test; p<0.01; Maximum # of intersections Paired t-test; p<0.01). We next examined microglial process coverage across one hour to determine whether the decreased process ramification during wakefulness resulted in decreased parenchymal surveillance. We found a significant reduction in the total parenchymal area surveyed in awake states as compared to anesthetized states, ( Fig.1e ,f; Paired t-test; p<0.05). To determine whether changes in surveillance were also a result of altered process dynamics, we measured the motility index across one hour. Surprisingly, process motility was higher in awake mice ( Fig.1g ,h; Supplementary Movies 1 and 2; Paired t-test; p<0.01). A more detailed analysis of the microglial process dynamics indicated that wakefulness did not alter microglial process instability ( Fig.1i ; Student's t-test; n.s.), while anesthesia enhanced microglial process stability ( Fig.1j ; Student's ttest; p<0.01).
Despite the animals being habituated to head restraint before imaging, it is possible that changes in microglial morphology and surveillance in awake animals are due to factors released as a result of increased stress. To test this possibility, we imaged microglia in animals that were exposed to restraint stress prior to anesthesia and found no difference in microglial motility, morphology or surveillance ( Supplementary Fig.1 ). We also determined that circadian rhythm did not alter the morphology, surveillance or motility of microglia ( Supplementary Fig.2 ). Based on these findings, we conclude that anesthesia decreases process motility by increasing stability, which results in a more complex morphology and higher process coverage of the brain parenchyma.
Anesthesia has diverse effects on brain function depending on the anesthetic used. To determine the cortical network state under the fentanyl cocktail, we collected local field potential (LFP) recordings in the cortex during anesthesia and wakeful states. As expected, delta wave power was significantly higher under anesthesia ( Fig.1k,l ), suggesting that the fentanyl cocktail puts the brain in a slow-wave dominated, "sleep-like" state. To disambiguate the effects of the different components of the fentanyl cocktail on microglia, and to more closely simulate a deep sleep state, we repeated our experiments using solely dexmedetomidine (DEX), which is a known sedative that reduces NE release from the locus coeruleus (LC) and approximates natural slowwave sleep 21 . DEX alone produced a robust increase in the microglial arbor ( Fig.2a-d ; AUC Paired t-test; p<0.0001; Maximum # of intersections; Paired t-test; p<0.05) and enhanced microglial surveillance ( Fig.2e,f ; Paired t-test; p<0.05). Microglia in animals dosed with DEX also had a lower rate of process motility recapitulating the fentanyl cocktail results ( Fig.2g ; Supplementary Video 3; Paired t-test; p<0.001). Likewise, this decreased motility was associated with decreased process instability and increased process stability ( Fig.2h ,i; instability; Paired t-test; p<0.001; stability; Paired t-test; p<0.001;). These data suggest that inducing a slow-wave sleep like state using DEX is sufficient to elicit a profound enhancement of microglial surveillance of the parenchyma.
Anesthesia facilitates the microglial response to focal tissue injury
Given the significant impact of anesthesia on microglial surveillance and morphology, we next wanted to establish if these changes could affect targeted microglial responses to acute injury. To test this possibility, we generated focal laser ablation injuries in the cortex of the same mice while they were either awake or anesthetized, and quantified the microglial injury response of microglia in the immediate surrounding tissue over an hour ( Fig.3a,b ; Supplementary Videos 4 and 5). We found that anesthesia significantly increased the microglial response to focal tissue injury ( Fig.3c -e; AUC; Paired t-test; p<0.05; Max response; Paired t-test; n.s.). The enhanced injury response and increased basal stability in anesthetized conditions suggest that wakefulness exerts a primarily inhibitory effect on microglial dynamics that is alleviated by sedation.
β2 Adrenergic receptor signaling and noradrenergic tone alter microglial dynamics
To dissect the underlying mechanisms responsible for our observations, we considered signaling pathways in microglia that are likely to be dependent on wakeful states and that could affect microglial process stabilization. One prominent candidate is NE because DEX treatment decreases cortical NE levels, which could explain the microglial effects we observe following DEX administration. Furthermore, NE is a powerful mediator of wakefulness with decreased concentrations in the cortex during anesthesia 19, 22 . NE exerts diverse effects on multiple cell types through a family of G-protein coupled receptors. Though it is possible that NE exerts its effects on microglia through indirect pathways involving other cell types, we focused on the direct effect on β2-ARs because microglia are known to express β2-ARs at higher levels than other CNS cell types in the healthy brain. 20 In addition, previous work in vitro work has demonstrated that microglial β2-AR signaling can inhibit chemotaxis towards ATP 23 . To test whether β2-AR signaling alters microglial dynamics in vivo, we systemically applied the blood-brain barrier (BBB) permeant, β2-AR selective agonist, clenbuterol. To account for indirect clenbuterol effects through the periphery, mice were pre-dosed with the BBB impermeant, non-selective β-antagonist, nadolol at least 1 hour prior to clenbuterol dosing. Clenbuterol treatment caused a significant and sustained retraction of microglial processes, resulting in microglia that resemble those seen in awake mice ( Fig.4a ). Microglial pseudopodia retracted within the first 30min of imaging and remained retracted for the second half-hour of imaging ( Fig.4b ; Two-way ANOVA; p<0.0001). The retraction of pseudopodia was accompanied by a concomitant loss of de novo pseudopodia formation from 0-30min ( Supplementary Fig.3 ). In addition, we also observed a persistent decrease in microglial motility as compared to saline-treated mice ( Fig.4c ; Two-way ANOVA; p<0.01). In order to further validate that the effects of β2-AR agonism on microglia were a direct effect on microglia and not due to peripheral activation of β2-ARs, we directly applied a selective β2-AR agonist, terbutaline, through an acute craniotomy and replicated our effects from the i.p. clenbuterol administration ( Supplementary Fig.4 , and Supplementary Video 6).
In order to further quantify the impact of clenbuterol on microglia we traced individual microglia and used Sholl analysis to assay the complexity of the arbor. We found that microglia treated with clenbuterol two hours before imaging had significantly reduced arbor complexity ( Fig.4d -g; AUC; one-way ANOVA; p<0.0001; Maximum # of intersections; one-way ANOVA; p<0.0001). Clenbuterol-treated animals also had a significant decrease in microglial process coverage of the parenchyma over one hour ( Fig.4h ,i; one-way ANOVA; p<0.0001). We also wanted to assess if our observed effects of acute clenbuterol administration produced sustained changes in microglial dynamics beyond the initial hour post-administration. Examining microglial motility, we found it was significantly reduced in clenbuterol-treated animals (3 hours postadministration), although the effect was significant only in female mice ( Fig. 4j ; Two-way ANOVA; p<0.01).
To further dissect the effects of β2-AR signaling on microglial dynamics, we assayed microglial motility in animals treated with different pharmacological manipulations of β2-AR or NE signaling. We asked whether reducing microglial β2-AR signaling affected microglial dynamics. We administered the β2-AR antagonist, ICI-118,551 (at time of imaging) to selectively block β2-AR signaling and depleted cortical NE using N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4, a neurotoxin selective for noradrenergic neurons). Neither treatment affected microglial surveillance ( Fig.4h ,i), although DSP4 reduced microglial motility in female mice ( Fig.4j ; Supplementary Movies 7-11; two-way ANOVA; p<0.05). The reductions in motility were associated with decreased instability in females and enhanced stability in both males and females ( Supplementary Fig.5 ).
Effects of modulating β2 -ARs in awake mice
Because β2-AR stimulation decreased microglial ramification and decreased motility in anesthetized animals, we next asked whether blocking or stimulating β2-AR signaling in awake mice affected microglial morphology and dynamics. Microglia imaged through cranial windows in awake mice were treated with either clenbuterol or ICI-118,551 to selectively stimulate or block β2-AR signaling respectively ( Fig. 5a ). Sholl analysis revealed that clenbuterol had no effect on microglial ramification in awake mice ( Fig.5a-d ; AUC; Paired t-test; n.s.; Maximum # of intersections; Paired t-test; n.s.). However, there was a significant increase in microglial ramification in ICI-118,551-treated animals as evidenced by an increased area under the Sholl curve and increase in max intersections ( Fig.5a -b,e-f; AUC; Paired t-test; p<0.001; Max response; Paired t-test; p<0.0001). We found that clenbuterol significantly reduced microglial surveillance of the parenchyma, despite the lack of impact on microglial arborization ( Fig.5g ,h; Paired t-test; p<0.01). We also found that ICI-118,551-treated microglia showed enhanced surveillance of the parenchyma ( Fig.5g ,I; Paired t-test; p<0.05). In addition, we examined motility and found that clenbuterol significantly reduced microglial motility in awake mice ( Fig.5j ; Paired t-test; p<0.05), and that ICI-118,551 significantly increased microglial motility in awake mice ( Fig.5k ; Supplementary Video 12; Paired t-test; p<0.05;). Combined with our previous data in awake vs. anesthetized mice, these data suggest that during wakeful conditions, microglial ramification and process motility are inhibited by endogenous norepinephrine, and that relieving this inhibition via β2-AR antagonism induces an increase in process ramification and surveillance recapitulating the effects of anesthesia.
β2-AR signaling impacts microglial response to focal tissue injury
Previous work has shown that both NE and β-AR stimulation blocks microglial process chemotaxis in vitro 23 suggesting that β-AR signaling may attenuate microglial responses to injury.
To determine whether this is also true in vivo, we created a focal laser tissue injury in adolescent mice and observed reduced microglial process recruitment to the lesion core in clenbuterol treated mice ( Fig.6a,b ). We observed that peak response and overall microglial response to the injury was significantly reduced in clenbuterol-treated mice ( Fig.6c -e; One-way ANOVA; p<0.0001).
Furthermore, there was a trend towards and increased response in nadolol-or ICI-118,551treated mice ( Fig.6d ; One-way ANOVA; p<0.0001). These data suggest that microglial β2-AR signaling attenuates not only baseline surveillance, but also the response to changes in CNS homeostasis during acute injury.
Noradrenergic signaling and microglial β2-AR stimulation impair critical period ocular dominance plasticity.
After observing the robust effects of noradrenergic and β2-AR signaling on microglia, we asked whether this signaling pathway mediates microglial roles in synaptic plasticity. Previously published work in our lab has shown that microglial processes interact with neural elements in vivo 4, 7, 10 and that these interactions can be modulated by visual experience 4 . We have also shown that during the mouse adolescent visual critical period perturbation of microglial purinergic signaling through P2Y12 impairs ocular dominance plasticity (ODP) 10 . Given the antagonistic effect of β2-ARs on P2Y12 signaling 23 , we hypothesized that microglial β2-AR signaling might impair ODP during the peak of the mouse visual critical period (~P25-P32 24, 25 ) , when our experiments have demonstrated altered microglial phenotypes ( Fig. 4 ). Selectively activating β2-ARs chronically with clenbuterol effectively blocked ODP, indicated by the lack of ocular dominance shift of neuronal responses after four days of monocular deprivation ( Fig.7b ;Two-way ANOVA; p<0.001). As before, nadolol was administered with clenbuterol to block peripheral β2-AR stimulation. Both saline-treated and nadolol-only treated animals showed normal ocular dominance shifts indicating intact ODP ( Fig.7a,b ). In addition, cortical NE depletion with DSP4 treatment impaired ODP confirming previous work demonstrating that NE has important roles in ODP ( Fig.7b) 26 . However, this effect appeared to be independent of β2-AR signaling as chronic blockade of β2-ARs with ICI-118,551 did not impact ODP ( Supplementary Fig.6 ). Thus, sustained stimulation of β2-AR signaling interferes with the plastic processes that mediate ODP, but NE signaling through other signaling pathways are necessary for ODP 27 .
Microglial β2-AR activation impairs ocular dominance plasticity
Despite the known roles of microglia in ocular dominance plasticity and high microglial β2-AR expression, it is possible that pharmacological β2-AR stimulation impairs ODP through nonmicroglial pathways. To determine whether our results are specifically due to β2-AR signaling in microglia, we crossed the CX3CR1Cre-ERT 9 mouse line to β2-AR floxed mice 28 to selectively ablate β2-ARs in microglia. Mice were dosed with tamoxifen from ~p2-4 9 to ensure that β2-ARs were selectively ablated from microglia in adolescent mice. Microglia were isolated from tamoxifen-treated animals and successful gene excision of β2-ARs confirmed by PCR ( Supplementary Fig.7 ). To test whether the effects of β2-AR stimulation on microglial dynamics were dependent on microglial β2-AR expression, we labeled microglia by crossing these mice with the tdTomato-labeling, Ai9 line. Clenbuterol no longer induced a retraction of the microglial arbor in tamoxifen-treated Cx3cr1Cre-ERT-Het/β2-ARflx/Ai9 mice, while the response was intact in control, tamoxifen-treated Cx3cr1Cre-ERT-Het/Ai9 mice ( Fig. 7c,d ; Two-way ANOVA; p<.0001), further confirming loss of these receptors from microglia. We then repeated ODP experiments with tamoxifen-treated Cx3cr1Cre-ERT-Het controls and Cx3cr1Cre-ERT-Het/β2-ARflx (Cx3cr1Cre/β2-ARflx) mice ( Fig.7e-h ). Control mice showed the same effects of pharmacological manipulation as C57BL/6J mice ( Fig.7f ; Two-way ANOVA; p<0.05). Cx3cr1Cre/β2-ARflx mice lacking microglial β2-ARs showed normal ODP, suggesting that microglial β2-ARs are not necessary for ODP. We found that ablating β2-ARs in microglia, however, rescued ODP during chronic clenbuterol administration ( Fig.7g ,h; Two-way ANOVA; n.s. interaction), suggesting that aberrant activity of microglial β2-ARs interferes with normal plasticity. DSP4 treatment still blocked ODP in the Cx3cr1Cre/β2-ARflx mice ( Fig.7h ; Two-way ANOVA; Bonferroni post-hoc; p<0.05), showing that the effects of depleting NE are mediated by other cell types. Thus, we confirmed that chronic stimulation of microglial-specific β2-ARs is capable of blocking ODP while cortical NE depletion likely blocks ODP through non-microglial mechanisms.
Discussion
We report that the microglial β2-AR is a key receptor in regulating basal microglial surveillance and injury response in the visual cortex of awake mice, and that chronic pharmacological stimulation of this receptor during the mouse adolescent visual critical period impairs cortical experience-dependent plasticity. In wakeful conditions, microglial process arbors are small and highly motile, dominated mostly by filopodial protrusions. Anesthesia rapidly increases microglial arborization and pseudopodia stabilization allowing microglial processes to survey a larger area of cortex and respond more rapidly to a focal injury. Administration of the β2-AR agonist clenbuterol in anesthetized mice results in microglial characteristics that resemble the awake state, while the β2-AR antagonist ICI-118,551 generates microglial phenotypes that resemble anesthetized conditions in awake mice, suggesting that signaling through this microglial receptor regulates microglia function during wakefulness. Our findings indicate that there are robust differences in microglial basal dynamics between awake and anesthetic states and that these changes are driven by noradrenergic β2-AR signaling in microglia ( Fig.8 ).
Endogenous NE is a potent modulator of microglial function NE is a potent neuromodulator that regulates brain function and elicits transitions between internal states such as wakefulness, arousal, and stress. NE has many targets throughout the nervous system and can coordinate synchronized changes in multiple cell types through both tonic signaling during wakefulness and phasic firing to salient or noxious stimuli. 19 Astrocytic calcium signaling is robustly regulated by NE, 15, 29 which can impact potassium buffering, neurovascular coupling, neural metabolism, and neurotransmitter recycling. 30 Astrocytic function is also highly dependent on brain state with different roles during sleep, when NE is low, and wakefulness or stress, when NE is high 22 . Here we provide evidence that microglia are another target for NE signaling. Our work suggests that microglia, like astrocytes, may differ robustly between the awake and anesthetized or "sleep-like" state. While we could not quantify microglial dynamics in sleeping animals, due to the fact that mice have very short sleep cycles 22, 31 , our experiments with dexmedetomidine suggest that microglia may also show enhanced surveillance and injury responses during sleep. Dexmedetomidine is thought to hyperpolarize LC neurons and inhibit NE release throughout the brain 21 , leading to brain activity that resembles more prolonged slow-wave sleep in humans 31 . Thus, our work indicates that microglia may have different functions in the awake vs. sleeping brain. This idea merits further investigation, as many diseases are linked to changes in sleeping patterns, and the quality of sleep can in turn greatly impact disease progression 32 .
Noradrenergic inhibition of microglial dynamics impairs synaptic plasticity, suggesting that brain state, through noradrenergic signaling, modulates microglia-synapse interactions 4 . Simulating a chronic awake state through pharmacological targeting of microglial β2-ARs prevents ODP, further suggesting that microglia require a release from noradrenergic signaling in order to fulfill essential roles in neural plasticity. This implies that in physiological conditions NE may be exerting an important inhibitory function on microglia, perhaps preventing inappropriate or excessive microglia-neuron interactions. In the awake behaving state tonic NE release decreases neural variability in firing rates and is thought to enhance the signal to noise ratio in the visual cortex 33 . NE bulk release from varicosities could enhance neural tuning while simultaneously inhibiting microglial-neuron interactions through selective activation of β2-ARs. Previous work has demonstrated that sleep is necessary for plasticity, as well as specifically for ODP 34 , and while a multitude of signals are regulated by sleep, microglial β2-AR signaling may be an additional target. It is also important to note that microglial P2Y12 is necessary for ODP and both genetic and pharmacological inhibition results in the loss of plasticity 10 . Thus, it is likely that interactions between β2-AR and P2Y12 signaling in microglia regulate microglial roles at synapses. Effects of NE on microglia and plasticity may also be mediated by NE signaling in other cell types. In our study, depletion of NE with the neurotoxin DSP4 blocked ODP and affected microglial motility, however ablation of microglial β2-ARs failed to rescue plasticity in DSP4 treated mice. This suggests that loss of NE in this model signals through a different receptor or cell-type to alter microglial dynamics and plasticity. Interestingly, astrocytes have robust expression levels of α1, α2, and β1, ARs which contribute to astrocytic metabolic coupling and K+ clearing during neural activity 19 . The diverse effects of NE on astrocytic function could make astrocytes an intermediary by which depletion of NE may be altering both microglial function and neural plasticity. It is also important to note that selective β2-AR signaling does not account for all changes in microglial dynamics. Wakefulness and β2-AR stimulation had opposite effects on microglial motility suggesting that motility per se is regulated through a different signaling pathway possible initiated by NE signaling in other cell types. The regulation of glymphatic flow by wakefulness may be an additional mechanism by which NE signaling in other cell types may influence microglial dynamics, in this case by altering extracellular space 16 .
Intracellular signaling effectors of β2-AR in microglia β2-AR and P2Y12 signaling have opposite effects on microglial morphology, chemotaxis 35 and ODP. Both receptors are G-protein coupled. While P2Y12 is coupled to the Gi subunit, the β2 AR is coupled to Gs, suggesting that these may act in a push-pull system 23 (Fig. 8) . The intracellular pathways that mediate G protein signaling in microglia are still unclear largely because reduced preparations do not necessarily capture physiological microglial behavior. Ex vivo, β2-AR stimulation by NE and β2-AR agonists blocks P2Y12 process chemotaxis toward ATP by downstream protein kinase A (PKA) dependent phosphorylation of phosphoinositide 3-kinase gamma (PI3Kγ) 23, 36 , suggesting this pathway may be important. Push-pull signaling through adenylyl cyclase may also play a role. Recent studies in the acute brain slice have shown that baseline microglial motility relies on the maintenance of the microglial resting membrane potential by the two-pore domain channel THIK-1 37, 38 . Genetic or pharmacological perturbations of THIK-1 function reduce microglial ramification and surveillance, similarly to β2-AR stimulation, making it a likely target. While P2Y12 signaling does not alter basal surveillance in microglia, it does gate THIK-1 function causing hyperpolarization in response to ATP. β2-ARs could similarly interface with THIK-1 or Kir K + channels to alter the microglial resting membrane potential thereby inhibiting surveillance. This is the case in neurons of the medial prefrontal cortex, where clenbuterol hyperpolarizes fast-spiking GABAergic interneurons 39 due to β2-AR driven Gαs inhibition of inward Kir K + rectifying channels. β2-ARs could also regulate microglial motility through recruitment and signaling by β-arrestin1 and 2 which are both expressed in mouse microglia 40 and can have diverse downstream targets including cytoskeletal proteins 41 . Recent work in zebrafish showed a critical role of β-arrestin1 in maintaining normal microglial morphology, surveillance, and phagocytosis 42 . Long-term activation of β2-ARs can lead to heterologous desensitization and possible endocytosis of other GPCRs such as P2Y12 41 through β-arrestins. Activation of β-arrestin2 in microglia initiates longer term anti-inflammatory signaling through blockade of Mitogen-activated protein kinases (MAPKs) rescuing neuronal death in a Parkinson's disease model 43 . P2Y12 signaling can also drive IL-1β and inflammasome recruitment in response to LPS triggered inflammation 37 , suggesting that cytokine effectors may critically alter microglial and inflammatory milieu after activation of GPCRs. It is important to note that many forms of plasticity 44 , including ODP 45 , are thought to be mediated by cytokines, such as IL-1 β and TNFα, which are also known to promote sleep 46 . Our data suggests that microglial β2-AR signaling may be regulated by sleep-wake cycles. Microglial β2-ARs may in turn also alter sleep through regulation of cytokine production driven by downstream nuclear factor ϰβ signaling 47 . From previous work and our findings, a picture emerges of a delicate interplay between P2Y12 and β2-AR signaling which mediate the responsivity of microglia to acute perturbations in the CNS milieu.
Implications for understanding microglial signaling in disease
The diversity of intracellular signaling pathways down-stream of microglial β2-ARs make this receptor a fascinating target for the gating of microglial physiology and responses. Our results demonstrate profound effects of selective β2-AR stimulation and wakefulness on microglial behavior. These mechanisms may also have a large impact on disease processes. It has been well documented that sleep disturbances are a hallmark and some of the earliest indicators of the onset of neurodegenerative diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington disease (HD) 48 . In the case of AD, sleep deprivation and sleep loss lead to elevated levels of pathological tau and β-amyloid (Aβ), thereby worsening neural health and synapse loss. Interestingly, prolonged wakefulness and increased noradrenergic signaling prevent adequate astrocyte-driven glymphatic clearance of Aβ 16 . Sleep loss in AD could initiate a range of deleterious processes by increasing noradrenergic signaling: a failure of astrocytic clearance mechanisms permitting accumulation of toxic proteins such as Aβ with an accompanying failure of microglial surveillance and recruitment to sites of injury and degeneration due to enhanced β2-AR activity. On the other hand, NE has been shown to have beneficial roles on microglia in AD, where it enhances Aβ plaque clearance by microglia while simultaneously dampening the production of proinflammatory cytokines 49 . This is in line with other disease models. For instance, in a model of PD, β2-AR activation enhances microglial anti-inflammatory signaling rescuing neural cell death 43 . Similarly, in kainate-induced seizures, β2-AR activation promotes an anti-inflammatory phenotype in microglia decreasing damage and neural apoptosis 50 . While we found that acute noradrenergic signaling inhibits microglial recruitment to acute tissue damage, NE may be helpful in mediating microglial responses to chronic degenerative disease states. Further research is needed to characterize the conditions where β2-AR activation and suppression of microglial responses by promoting an anti-inflammatory phenotype are either beneficial or deleterious for disease resolution.
Altogether, our data show that microglial β2-ARs are potent regulators of microglial dynamics and visual system experience-dependent plasticity. While future work is needed to address how microglia change during physiological sleep processes, our study provides promising evidence that microglia have critically different roles in the sleeping and awake brain. .0120, t(7)=3.366). (i) There was no corresponding change in process instability (n=4m/4f, Paired t-test, P=0.2053, n.s., t(7)=1.396). (j) Our decreased motility in the anesthetized state did correspond to a significant increase in microglial process stabilization (n=4m/4f, Paired t-test, P=0.0011, t(7)=5.318).(k) Example local field potential (LFP) traces from mice in anesthetized and awake mice with thin skull preparations. (l) Normalized delta-power from LFP recordings in awake and anesthetized states demonstrating decreased delta-power in the awake state and increased delta power in the anesthetized state. Scale bars 20μm. Graphs show mean + s.e.m. Individual points represent individual animals. Lab) mice to generate mice which had β2ARs selectively knocked out of microglia. CX3CR1-Cre ERT mice were also bred to Ai9 4 (tdTomato JAX: 007909) mice for visualization of microglia in 2-photon experiments. Mice were housed with a standard 12:12 light/dark cycle and fed standard chow ad libitum. For experiments regarding ocular dominance plasticity, mice were used in the visual critical period (P25-35). Sex distribution is provided in Supplementary Table 1 .
Stress Exposure. For stress exposure experiments, male and female mice were randomly assigned to control or stressed cohorts. Stressed mice were briefly anesthetized using 3% isoflurane and restrained in 50ml conical tubes drilled with air holes in a brightly lit fume hood for 2 hours. This stress period was repeated for three consecutive days at approximately the same time each day. Following the third day, mice were either imaged immediately following or 4 hours after the final stressor. Control mice were handled on each day but returned to their home cages.
Circadian Rhythm Measurements.
For circadian rhythm experiments, mice were kept at the standard 12:12 light/dark cycle with lights on at 6:00 and lights off at 18:00. For fixed-tissue analysis, brains were collected at 6:00, 12:00, 18:00, and 24:00. For in vivo experiments, animals were imaged at 12:00 and 24:00. For collection times during the dark cycle, cages were covered with a black sheet to minimize light exposure before experiments.
Flow isolation of microglia and confirmation of β2AR excision. We utilized our previously published experimental design 5 with a small modification to accommodate for the YFP expression in the CX3CR1-Cre ERT line. CX3CR1-Cre ERT / Adrbeta2-flox mice were either dosed with 50μg tamoxifen from P2-4 or undosed. At ~P28 mice were euthanized by an i.p. sodium pentobarbital overdose (Euthasol, Virbac) and transcardially perfused with ice cold 0.15 M PBS. Each brain was removed and the whole cortex was dissected from the rest of the brain in ice cold, degassed Cells were collected in PBS for DNA isolation with a Qiagen DNAeasy DNA isolation kit.
A total of 3 tamoxifen treated and 3 tamoxifen untreated animals were included in our confirmation experiments. Isolated DNA was run through 2 PCR protocols, 1 st the PCR for confirmation of floxed allele presence (550BP product: Fw: ccaaagttgttgcacgtcac, Rv: gcacacgccaaggagattat), and 2 nd excision confirmation(~800BP: Fw: ccaaagttgttgcacgtcac, Rv: aagaaagaggaggggctgag) 3 . We confirmed that in tamoxifen treated mice the 550BP floxed allele PCR product was no longer present (Supplementary figure 8) , and the excision product ~800BP was present. In our untreated mice we still had the 550BP floxed allele, however we did also see the ~800BP excision product in the second PCR. This suggests that there is a certain degree of leakiness in our Cre expression.
However, this leakiness did not affect our experimental outcomes as our controls for all CX3CR1-Cre ERT / Adrbeta2-flox experiments were CX3CR1-Cre ERT -HET mice dosed with tamoxifen.
Pharmacological Agents
Fentanyl cocktail [6] [7] [8] [9] : fentanyl (0.05mg kg -1 , i.p.), midazolam (5.0 mgkg -1 , i.p.), and dexmedetomidine (0.5 mgkg -1 ) Pre-mixed and given i.p. Used for anesthetized 2-photon imaging sessions and for thin-skull and cranial window procedures. Dexmedetomidine 10 : 0.4 mg kg -1 , i.p. 
Monocular deprivation.
Animals were randomly assigned to ND or 4MD cohorts starting from P27+2. MD animals were anesthetized (isoflurane, 5% induction, 3% maintenance). The right eyelids were trimmed and anti-biotic eye ointment was applied to the eye and trimmed margins. The eye was then sutured closed. Mice were given monitored and given carprofen (5 mg kg -1 ) every 24 hours for analgesia as needed. The eye was not reopened until the day of imaging and any animals with a compromised eye or sutures were excluded from the rest of the experiment. Cranial Window Surgery. Animals were anesthetized using the fentanyl cocktail during the cranial window implantation surgical procedure. Lubricant ointment was used to keep the eyes moist and protected. Body temperature was maintained at 37C during the surgery. Asceptic technique was adhered to during all surgical procedures: all tools were autoclaved for steam sterilization, and tools were sterilized in a bead sterilizer between surgeries (up to 3 uses). Mice were mounted in a stereotaxic frame and head-fixed for surgical procedures. The skull was exposed through a scalp incision and all connective tissues were cleared off the skull. A 3mm biopsy punch (Integra) was then used to create a circular score on the skull over V1. A 0.5 mm drill bit (FST) was used to then drill through the skull for the craniotomy, tracing the 3mm score.
A 5mm coverslip attached to a 3mm coverslip (Warner Instruments) by UV glue (Norland Optical Adhesive, Norland Inc) was then slowly lowered down into the craniotomy (3mm side down). The coverslip was carefully secured with Loctite 404 glue (Henkel Corp). A custom headplate produced by emachine shop (www.emachineshop.com) (designs courtesy of the Mriganka Sur Lab, MIT) was then secured onto the skull utilizing C&B Metabond dental cement (Parkell Inc).
The cement was then used to cover the rest of skull and seal the incision site. Animals were administered slow-release buprenex by URMC veterinary staff (s.q. mg kg -1 every 72 hours) and monitored for 72 hours post-op.
Two-Photon Microscopy
A custom two-photon laser-scanning microscope was used for in vivo imaging (Ti:Sapphire, Mai-Tai, Spectra Physics; modified Fluoview confocal scan head, 20x lens, 0.95 numerical aperture, Olympus). Excitation for fluorescent imaging was achieved with 100-fs laser pulses (80MHz) at 920nm for GFP and 1020nm for tdTomato with a power of ~40mW measured at the sample. For motility experiments in CX3CR1-GFP mice a 580/180 (GFP) filter was used. For experiments in CX3CR1-Cre+/Ai9 mice a 565 a 578/105 filter was used. During anesthetized cranial window imaging sessions mice were anesthetized with our fentanyl cocktail. Prior to awake imaging sessions mice were trained for three consecutive days in head-restraint on a running wheel progressing from 30 minutes to 1 hour of head-restraint over the three days. During awake imaging sessions mice were head-restrained and kept on a foam running wheel for the duration of the session, the restraint apparatus and wheel were the same as were used in the initial training sessions. During thin-skull 6,7,9 imaging sessions mice were anesthetized with the fentanyl cocktail prior to the skull-thinning surgery and for the duration of the imaging session. During imaging sessions and during post imaging recovery mice were kept at 37C until they were alert. Imaging was conducted at 3-5 digital zoom and 1um z-step, with time-lapse imaging at 5-minute intervals Microglial pseudopodia measurements: For pseudopodia analysis t=0, t=30, and t=60 minutes from the motility imaging sessions were used to create 0-30-and 30-60-minute overlays. The number of pseudopodia were then counted using the multipoint tool in imageJ to track marked pseudopodia. Pseudopodia were defined as bulbous end-tips of microglial processes. Retraction and extension ratios were calculated based on the number of retracted or extended pseudopodia divided by the total pseudopodia counted. For imaging of Ai9 animals, only 0 and 30 minute timepoints were taken as the tdTomato fluorophore suffered from pronounced photobleaching with repeated imaging. This precluded the use of Ai9 for motility measurements.
Terbutaline Motility: For direct application of terbutaline to the brain parenchyma, small craniotomies were performed on anesthetized animals and imaged directly without a coverslip.
Baseline imaging was collected every 2 minutes for 30 minutes in a sterile saline objective immersion. Following baseline, immersion media was either replaced by additional sterile saline, or terbutaline in sterile saline (1mM) to allow for pharmacological diffusion into the brain parenchyma and imaged for an additional 60 minutes. Baseline periods and saline treated animals controlled for microglial activation due to craniotomies and animals that had significant motility or morphological changes during the baseline were removed from the study.
Laser Ablation: Laser ablation injuries were created by running a point scan for 8s at 780nm using ~75mW at the sample. The microglial injury response was imaged by collecting Z-stacks of 50-90μm every 5 minutes. For analysis, z-projections were all comprised of 10µm of the stack, encompassing the approximate center ablation core. The file was converted to an avi and subjected to analysis by a custom MATLAB script designed to calculate the movement of microglial processes towards the ablation core. Briefly, for each pixel at each time point the script generates a vector which estimates the magnitude and direction of motion of the pixel utilizing the Farneback method for estimating optic flow 15 . We then selected to only include vectors which were directed towards the ablation core to exclude motion not directed towards the injury core.
We also filtered out vectors below 5 pixels of motion as these were identified as primarily noise in our imaging sessions. To quantify the generated vectors we summed the magnitudes of all the vectors at each time point and normalized this value to the total number of pixels in the image.
The first time-point was excluded from all analysis as the script estimates the first time point's movement by assuming a blank frame preceding the first time point. We then found the area under the curve for our injury response normalized magnitude as well as the maximum value of our normalized magnitude over the 1hr session.
Code Availability. MATLAB code for motility and laser ablation analysis is available on request from the corresponding author.
Histology. Whole brains were collected following transcardial perfusion and overnight postfixation with paraformaldehyde (4%). Tissue was cryoprotected and coronal sections were cut on a freezing microtome (Microm; Global Medical Instrumentation, Ramsey, MN) at 50-μm thickness.
Sections were processed free-floating at room temperature (RT). Briefly, sections were rinsed, and endogenous peroxidase activity and nonspecific binding blocked with a 10% BSA solution.
Sections were then incubated in a primary antibody solution (24 h, 4 o C, anti-Iba-1, 1:1,000, Wako #019-19741) followed by secondary antibody solution (4 h, RT, Alexa-Fluor 488, 1:500, Invitrogen), mounted and coverslipped. For examination of microglial ramification containing primary visual cortex were identified and imaged on a Zeiss LSM 510 confocal microscope (Carl Zeiss, Thornwood, NY). For each section, a 10um z-stack in the center of the tissue was collected with a z-step of 1 um at 40x magnifications. Analysis was performed offline in ImageJ. Z-stacks were smoothed and compressed into a single z-projection. For analysis of ramification, microglia whose entire process arbor was contained within the image were individually selected and cropped into a new image. Each image was thresholded to generate a binarized outline of the process arbor, filtered to remove artifacts and analyzed with an automated Sholl analysis plugin (kindly provided by the Anirvan Ghosh laboratory, UCSD). 
Statistics
